Application 215256
- Type
- NDA
- Sponsor
- NOVO NORDISK INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | WEGOVY | SEMAGLUTIDE | INJECTABLE;INJECTION | 0.25MG | No | No |
| 002 | WEGOVY | SEMAGLUTIDE | INJECTABLE;INJECTION | 0.5MG | No | No |
| 003 | WEGOVY | SEMAGLUTIDE | INJECTABLE;INJECTION | 1MG | No | No |
| 004 | WEGOVY | SEMAGLUTIDE | INJECTABLE;INJECTION | 1.7MG | No | No |
| 005 | WEGOVY | SEMAGLUTIDE | INJECTABLE;INJECTION | 2.4MG | No | No |
| 006 | WEGOVY HD | SEMAGLUTIDE | SOLUTION;SUBCUTANEOUS | 7.2MG/0.75ML (7.2MG/0.75ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N215256-001 | WEGOVY | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-002 | WEGOVY | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-003 | WEGOVY | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-004 | WEGOVY | SEMAGLUTIDE | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-005 | WEGOVY | SEMAGLUTIDE | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-006 | WEGOVY HD | SEMAGLUTIDE | 7.2MG/0.75ML (7.2MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-03-19 | |
| N215256-007 | WEGOVY | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-008 | WEGOVY | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-009 | WEGOVY | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-010 | WEGOVY | SEMAGLUTIDE | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-011 | WEGOVY | SEMAGLUTIDE | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-012 | WEGOVY FLEXTOUCH | SEMAGLUTIDE | 9.6MG/3ML (3.2MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-06-18 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N215256-001 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-001 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-001 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-001 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-001 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-001 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-001 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-001 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-002 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-002 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-002 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-002 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-002 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-002 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-002 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-002 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-003 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-003 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-003 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-003 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-003 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-003 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-003 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-003 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-004 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-004 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-004 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-004 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-004 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-004 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-004 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-004 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-005 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-005 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-005 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-005 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-005 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-005 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-005 | 12029779 | 2038-10-10 | U-3162 | 2024-07-09 | |
| N215256-005 | 12551536 | 2038-10-10 | U-4418 | 2026-03-02 | |
| N215256-005 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-005 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-006 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-03-31 | |
| N215256-006 | 9764003 | 2033-06-21 | U-4418 | 2026-03-31 | |
| N215256-006 | 10888605 | 2038-08-24 | U-4418 | Drug product | 2026-03-31 |
| N215256-006 | 11752198 | 2038-08-24 | U-4418 | Drug product | 2026-03-31 |
| N215256-006 | 12214017 | 2038-08-24 | U-4418 | Drug product | 2026-03-31 |
| N215256-006 | 12029779 | 2038-10-10 | U-4418 | 2026-03-31 | |
| N215256-006 | 12551536 | 2038-10-10 | U-4418 | 2026-03-31 | |
| N215256-006 | 11318191 | 2041-02-17 | U-4418 | Drug product | 2026-03-31 |
| N215256-007 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-06-23 | |
| N215256-007 | 9764003 | 2033-06-21 | U-3161 | 2026-06-23 | |
| N215256-007 | 12569543 | 2037-04-28 | U-4443 | 2026-06-23 | |
| N215256-007 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 12029779 | 2038-10-10 | U-3162 | 2026-06-23 | |
| N215256-007 | 12551536 | 2038-10-10 | U-4418 | 2026-06-23 | |
| N215256-007 | 11478533 | 2040-05-13 | U-3861 | 2026-06-23 | |
| N215256-007 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 11318191 | 2041-02-17 | U-4443 | Drug product | 2026-06-23 |
| N215256-007 | 11318191 | 2041-02-17 | U-4560 | Drug product | 2026-06-23 |
| N215256-008 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-06-23 | |
| N215256-008 | 9764003 | 2033-06-21 | U-3161 | 2026-06-23 | |
| N215256-008 | 12569543 | 2037-04-28 | U-4443 | 2026-06-23 | |
| N215256-008 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 12029779 | 2038-10-10 | U-3162 | 2026-06-23 | |
| N215256-008 | 12551536 | 2038-10-10 | U-4418 | 2026-06-23 | |
| N215256-008 | 11478533 | 2040-05-13 | U-3861 | 2026-06-23 | |
| N215256-008 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 11318191 | 2041-02-17 | U-4443 | Drug product | 2026-06-23 |
| N215256-008 | 11318191 | 2041-02-17 | U-4560 | Drug product | 2026-06-23 |
| N215256-009 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-06-23 | |
| N215256-009 | 9764003 | 2033-06-21 | U-3161 | 2026-06-23 | |
| N215256-009 | 12569543 | 2037-04-28 | U-4443 | 2026-06-23 | |
| N215256-009 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-009 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-009 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N215256-001 | I-935 | 2027-03-08 |
| N215256-001 | I-973 | 2028-08-15 |
| N215256-002 | I-935 | 2027-03-08 |
| N215256-002 | I-973 | 2028-08-15 |
| N215256-003 | I-935 | 2027-03-08 |
| N215256-003 | I-973 | 2028-08-15 |
| N215256-004 | D-190 | 2026-07-21 |
| N215256-004 | I-935 | 2027-03-08 |
| N215256-004 | I-973 | 2028-08-15 |
| N215256-005 | I-935 | 2027-03-08 |
| N215256-005 | I-973 | 2028-08-15 |
| N215256-006 | NS | 2029-03-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 12029779 | 2038-10-10 | U-3162 | 2024-07-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | D-190 | 2026-07-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | D-190 | 2026-07-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-001 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-001 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-002 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-002 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-003 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-003 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | D-190 | 2026-07-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-005 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-005 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-001 | NPP | 2025-12-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-001 | I-935 | 2027-03-08 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WEGOVY | SEMAGLUTIDE | A-S Medication Solutions | f5e548d0-cc79-4c34-a3f5-e20a5b8b6564 | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 215256 NDA215256 50090-5824 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0169-4501 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4501 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4501 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4505 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4505 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4505 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4517 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4517 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4517 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4524 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4524 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4524 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4525 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4525 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4525 | WEGOVY | semaglutide | Novo Nordisk | NDA | Current |
| 50090-5824 | WEGOVY | semaglutide | A-S Medication Solutions | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85892 | SUPPL | 2026-05-12 |
| 85515 | SUPPL | 2026-03-24 |
| 85499 | SUPPL | 2026-03-24 |
| 85452 | SUPPL | 2026-03-23 |
| 85190 | SUPPL | 2026-03-02 |
| 85178 | SUPPL | 2026-02-27 |
| 84885 | SUPPL | 2026-01-30 |
| 84943 | SUPPL | 2026-01-29 |
| 84296 | SUPPL | 2025-11-25 |
| 84279 | SUPPL | 2025-11-24 |
| 83779 | SUPPL | 2025-10-15 |
| 83774 | SUPPL | 2025-10-15 |
| 83118 | SUPPL | 2025-08-18 |
| 83106 | SUPPL | 2025-08-15 |
| 80472 | SUPPL | 2024-12-03 |
| 80452 | SUPPL | 2024-11-29 |
| 80167 | SUPPL | 2024-11-05 |
| 80134 | SUPPL | 2024-11-05 |
| 80129 | SUPPL | 2024-11-05 |
| 77775 | SUPPL | 2024-03-11 |
| 77770 | SUPPL | 2024-03-08 |
| 74874 | SUPPL | 2023-07-24 |
| 74868 | SUPPL | 2023-07-24 |
| 73508 | SUPPL | 2023-02-16 |
| 73507 | SUPPL | 2023-02-15 |
| 73054 | SUPPL | 2022-12-27 |
| 73037 | SUPPL | 2022-12-27 |
| 73036 | SUPPL | 2022-12-27 |
| 71941 | SUPPL | 2022-08-29 |
| 69772 | ORIG | 2021-12-27 |
| 67729 | ORIG | 2021-06-07 |
| 67725 | ORIG | 2021-06-07 |
| 67724 | ORIG | 2021-06-07 |